ArticleAnnals of hematology2024

XPO1 inhibition displays anti-leukemia efficacy against DNMT3A-mutant acute myeloid leukemia via downregulating glutathione pathway.

Xiaoya Cai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.